Patrick Osei‐Owusu

982 total citations
38 papers, 716 citations indexed

About

Patrick Osei‐Owusu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Patrick Osei‐Owusu has authored 38 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 8 papers in Genetics. Recurrent topics in Patrick Osei‐Owusu's work include Receptor Mechanisms and Signaling (9 papers), Neuroscience of respiration and sleep (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Patrick Osei‐Owusu is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuroscience of respiration and sleep (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). Patrick Osei‐Owusu collaborates with scholars based in United States, Japan and Italy. Patrick Osei‐Owusu's co-authors include Kendall Blumer, Karie E. Scrogin, Amy James, James W. Crane, Hans H. Dietrich, Robert P. Mecham, Russell H. Knutsen, Olaf Schneewind, Hwan Keun Kim and Dominique Missiakas and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Patrick Osei‐Owusu

36 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Osei‐Owusu United States 16 306 142 98 78 74 38 716
Zhuo Zhao China 15 806 2.6× 86 0.6× 36 0.4× 74 0.9× 82 1.1× 38 1.2k
Anu Punn United Kingdom 11 414 1.4× 91 0.6× 74 0.8× 18 0.2× 95 1.3× 11 939
Beyhan Cengiz Türkiye 17 439 1.4× 51 0.4× 55 0.6× 54 0.7× 63 0.9× 54 1.1k
Zheng He Australia 21 590 1.9× 53 0.4× 85 0.9× 43 0.6× 70 0.9× 72 1.4k
Gracious R. Ross United States 19 379 1.2× 209 1.5× 38 0.4× 42 0.5× 49 0.7× 49 1.0k
Sookja Kim Chung Hong Kong 14 400 1.3× 39 0.3× 44 0.4× 34 0.4× 55 0.7× 22 739
Yuriko Nagane Japan 27 449 1.5× 51 0.4× 42 0.4× 115 1.5× 60 0.8× 84 1.9k
Roshanak Razmpour United States 14 435 1.4× 34 0.2× 29 0.3× 81 1.0× 121 1.6× 17 1.1k

Countries citing papers authored by Patrick Osei‐Owusu

Since Specialization
Citations

This map shows the geographic impact of Patrick Osei‐Owusu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Osei‐Owusu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Osei‐Owusu more than expected).

Fields of papers citing papers by Patrick Osei‐Owusu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Osei‐Owusu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Osei‐Owusu. The network helps show where Patrick Osei‐Owusu may publish in the future.

Co-authorship network of co-authors of Patrick Osei‐Owusu

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Osei‐Owusu. A scholar is included among the top collaborators of Patrick Osei‐Owusu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Osei‐Owusu. Patrick Osei‐Owusu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Shenaz, Robert J. Gaivin, Zhiyu Liu, et al.. (2025). Fatty acid transport protein 2 inhibition enhances glucose tolerance through α cell–mediated GLP-1 secretion. Journal of Clinical Investigation. 135(23). 1 indexed citations
2.
3.
Preston, Kyle, Tatsuo Kawai, Keiichi Torimoto, et al.. (2024). Mitochondrial fission inhibition protects against hypertension induced by angiotensin II. Hypertension Research. 47(5). 1338–1349. 7 indexed citations
4.
Eguchi, Satoru, Keiichi Torimoto, Adebowale Adebiyi, et al.. (2024). Milestone Papers on Signal Transduction Mechanisms of Hypertension and Its Complications. Hypertension. 81(5). 977–990. 4 indexed citations
5.
Wei, Dongyu, Hareram Birla, Yannong Dou, et al.. (2023). PGE2 Potentiates Orai1-Mediated Calcium Entry Contributing to Peripheral Sensitization. Journal of Neuroscience. 44(1). e0329232023–e0329232023. 2 indexed citations
6.
7.
Weinberger, Jeremy, et al.. (2022). The susceptibility of cardiac arrhythmias after spinal cord crush injury in rats. Experimental Neurology. 357. 114200–114200. 4 indexed citations
8.
Xia, Jingsheng, et al.. (2022). Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias and disrupts the fine-tuning of Gi/o signaling. Journal of Molecular and Cellular Cardiology. 170. 34–46. 1 indexed citations
9.
Onken, Michael D., Carol M. Makepeace, Kevin M. Kaltenbronn, et al.. (2021). Targeting primary and metastatic uveal melanoma with a G protein inhibitor. Journal of Biological Chemistry. 296. 100403–100403. 32 indexed citations
10.
Oh, Junseo, Scot J. Matkovich, Amy E. Riek, et al.. (2020). Macrophage secretion of miR-106b-5p causes renin-dependent hypertension. Nature Communications. 11(1). 4798–4798. 27 indexed citations
11.
Xia, Jingsheng, Ipsita Mohanty, Shaili Aggarwal, et al.. (2019). Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for Gq/11 class G proteins. Pharmacological Research. 141. 264–275. 18 indexed citations
12.
Osei‐Owusu, Patrick, Valerie Bracchi‐Ricard, Roman Fischer, et al.. (2018). Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury. Journal of Neuroscience. 38(17). 4146–4162. 44 indexed citations
13.
Rurik, Joel G., et al.. (2017). Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of Gq/11 signaling and vascular contraction. Journal of Biological Chemistry. 292(47). 19266–19278. 8 indexed citations
14.
Li, Jie, et al.. (2017). Elastin insufficiency causes hypertension, structural defects and abnormal remodeling of renal vascular signaling. Kidney International. 92(5). 1100–1118. 12 indexed citations
15.
Osei‐Owusu, Patrick, et al.. (2016). Expression and Purification of N-Terminally His-Tagged Recombinant Type III Secretion Proteins. Methods in molecular biology. 1531. 183–191. 1 indexed citations
16.
Osei‐Owusu, Patrick & Kendall Blumer. (2015). Regulator of G Protein Signaling 2. Progress in molecular biology and translational science. 133. 77–92. 22 indexed citations
17.
Oladipupo, Sunday S., Craig Smith, Andrea Santeford, et al.. (2014). Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. Proceedings of the National Academy of Sciences. 111(37). 13379–13384. 103 indexed citations
18.
Osei‐Owusu, Patrick, Rasna Sabharwal, Kevin M. Kaltenbronn, et al.. (2012). Regulator of G Protein Signaling 2 Deficiency Causes Endothelial Dysfunction and Impaired Endothelium-derived Hyperpolarizing Factor-mediated Relaxation by Dysregulating Gi/o Signaling. Journal of Biological Chemistry. 287(15). 12541–12549. 40 indexed citations
19.
Osei‐Owusu, Patrick, et al.. (2006). The 5-Hydroxytryptamine1A Receptor Agonist, (+)-8-Hydroxy-2-(di-n-propylamino)-tetralin, Increases Cardiac Output and Renal Perfusion in Rats Subjected to Hypovolemic Shock. Journal of Pharmacology and Experimental Therapeutics. 320(2). 811–818. 11 indexed citations
20.
Osei‐Owusu, Patrick, Amy James, James W. Crane, & Karie E. Scrogin. (2005). 5-Hydroxytryptamine 1A Receptors in the Paraventricular Nucleus of the Hypothalamus Mediate Oxytocin and Adrenocorticotropin Hormone Release and Some Behavioral Components of the Serotonin Syndrome. Journal of Pharmacology and Experimental Therapeutics. 313(3). 1324–1330. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhuo Zhao Breakdown of academic impact, for papers by Anu Punn Breakdown of academic impact, for papers by Beyhan Cengiz Breakdown of academic impact, for papers by Zheng He Breakdown of academic impact, for papers by Gracious R. Ross Breakdown of academic impact, for papers by Sookja Kim Chung Breakdown of academic impact, for papers by Yuriko Nagane Breakdown of academic impact, for papers by Roshanak Razmpour
Rankless by CCL
2026